Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Metadata
Title
Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding
Authors
Thomas Heuser
Thomas Rink
Esra Weller
Hartmut Fitz
Hans-Herbert Zippel
Rolf Kreienberg
Thorsten Kühn
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010619223296

Other articles of this Issue 2/2001

Breast Cancer Research and Treatment 2/2001 Go to the issue

OriginalPaper

1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

OriginalPaper

Mammography utilization among California women age 40–49 in a managed care environment

OriginalPaper

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

OriginalPaper

Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens

OriginalPaper

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

BriefCommunication

BRCA1 and BRCA2: to test or not to test
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits